Review Article
Total Knee Arthroplasty Considerations in Rheumatoid Arthritis
Table 2
Literature review of DMARD safety in the perioperative period.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Methotrexate was held two weeks before until two weeks after surgery in this group. *Etanercept and adalimumab were held two weeks before until two weeks after surgery, while infliximab was held both four weeks prior to and after surgery. |